Literature DB >> 15220456

Bromodeoxyuridine-labeled viral particles as a tool for visualization of the immediate-early events of human cytomegalovirus infection.

Kyle Rosenke1, Elizabeth A Fortunato.   

Abstract

We describe here a simple method for labeling the genome of human cytomegalovirus, a large double-stranded DNA virus, with bromodeoxyuridine (BrdU). The labeled DNA was incorporated into viral particles, which were then collected in cell supernatant. To demonstrate the versatility and effectiveness of this method, labeled virions were used to study the immediate-early events of virus-host cell interaction via indirect immunofluorescence microscopy. It is our hope that this new methodology will prove useful in the study of binding, entry and viral genome deposition in diverse virus systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220456      PMCID: PMC434117          DOI: 10.1128/JVI.78.14.7818-7822.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection.

Authors:  G Elliott; P O'Hare
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Specific chromosome 1 breaks induced by human cytomegalovirus.

Authors:  E A Fortunato; M L Dell'Aquila; D H Spector
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Directional spread of an alpha-herpesvirus in the nervous system.

Authors:  L W Enquist; M J Tomishima; S Gross; G A Smith
Journal:  Vet Microbiol       Date:  2002-04-22       Impact factor: 3.293

4.  Electron microscopy of herpes simplex virus. I. Entry.

Authors:  C Morgan; H M Rose; B Mednis
Journal:  J Virol       Date:  1968-05       Impact factor: 5.103

5.  p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus.

Authors:  E A Fortunato; D H Spector
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus.

Authors:  C Sinzger; M Kahl; K Laib; K Klingel; P Rieger; B Plachter; G Jahn
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

7.  Incorporation of green fluorescent protein into the essential envelope glycoprotein B of herpes simplex virus type 1.

Authors:  Corinne Potel; Karin Kaelin; Isabelle Gautier; Pierre Lebon; Jacques Coppey; Flore Rozenberg
Journal:  J Virol Methods       Date:  2002-08       Impact factor: 2.014

8.  Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid.

Authors:  K Ogawa-Goto; K Tanaka; W Gibson; E Moriishi; Y Miura; T Kurata; S Irie; T Sata
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169).

Authors:  J C Tamashiro; L J Hock; D H Spector
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

10.  Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment.

Authors:  A M Ishov; R M Stenberg; G G Maul
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

View more
  18 in total

1.  Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.

Authors:  Ian B DeMeritt; Jagat P Podduturi; A Michael Tilley; Maciej T Nogalski; Andrew D Yurochko
Journal:  Virology       Date:  2005-11-21       Impact factor: 3.616

2.  Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7.

Authors:  Sama Tamrakar; Anokhi J Kapasi; Deborah H Spector
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication.

Authors:  Stacy R Cantrell; Wade A Bresnahan
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment.

Authors:  Vivek Vikram Singh; Dipanjan Dutta; Mairaj Ahmed Ansari; Sujoy Dutta; Bala Chandran
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity.

Authors:  Jennifer D Oduro; Ralf Uecker; Christian Hagemeier; Lüder Wiebusch
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

6.  Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle.

Authors:  Martin Zydek; Christian Hagemeier; Lüder Wiebusch
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

7.  Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells.

Authors:  Min Hua Luo; Elizabeth A Fortunato
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

8.  Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection.

Authors:  Shihao Xu; Xenia Schafer; Joshua Munger
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

9.  An endogenous accelerator for viral gene expression confers a fitness advantage.

Authors:  Melissa W Teng; Cynthia Bolovan-Fritts; Roy D Dar; Andrew Womack; Michael L Simpson; Thomas Shenk; Leor S Weinberger
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

10.  Infection of a Single Cell Line with Distinct Strains of Human Cytomegalovirus Can Result in Large Variations in Virion Production and Facilitate Efficient Screening of Virus Protein Function.

Authors:  Anamaria G Zavala; John M O'Dowd; Elizabeth A Fortunato
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.